Background: Low-level laser therapy (LLLT) in the early stage of bone healing was demonstrated as a positive local biostimulative effect. It was also shown that platelet-rich fibrin (PRF) and nanohydroxyapatite alloplast (NanoHA) are effective in treating periodontal intrabony defects.
Aim: The study aimed to evaluate the combined effects of LLLT (810 nm), PRF and NanoHA on induced intrabony periodontal defects healing.
Material And Methods: The study was conducted on 16 defects in 8 adult male rabbits (n = 16) divided into 4 groups; Control non-treated group (C), laser irradiated control group (CL), PRF+NanoHA graft (NanoHA-Graft+PRF) treated group and laser irradiated and treated group (NanoHA-Graft+PRF+L). CT radiography was made at baseline, 15 and 30 days later. The defects were induced in the form of one osseous wall defects of 10 mm height, 4 mm depth between the 1 and the 2 molars using a tapered fissure drill coupled to a high-speed motor. Statistical analysis was done using ANOVA.
Results: (NanoHA-Graft+PRF+L) group significantly produced bone density higher than C, CL and NanoHA-G+PRF alone.
Conclusion: The combination of LLLT+PRF+NanoHA as a treatment modality induced the best results in bone formation in the bone defect more than LLLT alone or PRF+NanoHA alone.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614254 | PMC |
| http://dx.doi.org/10.3889/oamjms.2019.484 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Saving a hopeless tooth with a four-wall bone defect: A case report.
Clin Adv Periodontics
December 2024
Department of Periodontal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Background: Recombinant human fibroblast growth factor-2 (rhFGF-2) has been shown to effectively promote the formation of new periodontal tissues, and its efficacy has been demonstrated in clinical settings. Moreover, the clinical and radiographic outcomes in the treatment of periodontal infrabony defects can be improved by using rhFGF-2 in combination with a bone substitute. Here, we present a case of four-wall bone defect in a tooth treated by combination regenerative therapy using rhFGF-2 and beta-tricalcium phosphate (β-TCP).
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to evaluate the effectiveness of combining enamel matrix derivatives (EMD) with bone substitutes (BG) in treating periodontal defects compared to using bone substitutes alone.
- Researchers analyzed data from 9 randomized controlled trials with a minimum follow-up of 6 months, focusing on intrabony and furcation defects.
- The results showed that the EMD+BG combination led to a significant improvement in clinical attachment levels for intrabony defects over a 12-month period, but no benefits were observed for furcation defects.
CALCIUM PHOSPHATE GRAFTS COMBINED WITH GUIDED TISSUE REGENERATION IN THE TREATMENT OF PERIODONTAL BONY DEFECTS- A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Evid Based Dent Pract
December 2024
Assistant Professor, Department of Restorative Dentistry, Maurice H. Kornberg School of Dentistry, Temple University, Philadelphia, PA.
Background: The objective of this systematic review is to assess the clinical outcomes of intrabony and furcation defects treated using a regenerative approach with calcium phosphate (CP) grafts combined plus guided tissue regeneration (GTR) membrane in comparison to open flap debridement (OFD).
Method: A review protocol was created under PRISMA checklist to find randomized clinical trials (RCTs) in English that compared CPs plus GTR with OFD in humans with intrabony and/or furcation defects. Both electronic and manual searches were conducted.
Latest update on the use of recombinant growth factors for periodontal regeneration: existing evidence and clinical applications.
Ther Adv Chronic Dis
November 2024
Division of Periodontology, Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA 02115, USA.
Growth factors were introduced to increase predictability in periodontal regeneration and have since been widely applied in dentistry. This narrative review article highlights histological and latest findings of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and recombinant human fibroblast growth factor-2 (rhFGF-2) for periodontal regeneration. rhPDGF-BB enhances the proliferation and chemotaxis of periodontal ligament and alveolar bone cells.
View Article and Find Full Text PDFA Comparative Evaluation of Allogenic Cancellous Particulate Chips and Autologous Bone Graft From Symphysis in the Regeneration of Periodontal Intrabony Defect: A Randomized Controlled Clinico-Radiographic Study.
Cureus
October 2024
Periodontology, Subharti Dental College and Hospital, Swami Vivekanand Subharti University, Meerut, IND.
Background and objective Periodontal therapy primarily aims to regenerate periodontal supporting tissues lost due to periodontitis. Autogenous bone grafts (ABG) are viewed as the gold standard method in bone regeneration and they have fewer drawbacks. Hence, many different bone-regenerating materials can be used including allografts, which have excellent biological qualities.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!